1. Home
  2. SEPN vs BTBT Comparison

SEPN vs BTBT Comparison

Compare SEPN & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • BTBT
  • Stock Information
  • Founded
  • SEPN 2022
  • BTBT 2015
  • Country
  • SEPN United States
  • BTBT United States
  • Employees
  • SEPN N/A
  • BTBT N/A
  • Industry
  • SEPN
  • BTBT Finance: Consumer Services
  • Sector
  • SEPN
  • BTBT Finance
  • Exchange
  • SEPN NYSE
  • BTBT Nasdaq
  • Market Cap
  • SEPN 453.2M
  • BTBT 437.8M
  • IPO Year
  • SEPN 2024
  • BTBT 2018
  • Fundamental
  • Price
  • SEPN $10.41
  • BTBT $2.33
  • Analyst Decision
  • SEPN Buy
  • BTBT Strong Buy
  • Analyst Count
  • SEPN 4
  • BTBT 3
  • Target Price
  • SEPN $27.00
  • BTBT $6.33
  • AVG Volume (30 Days)
  • SEPN 559.2K
  • BTBT 15.0M
  • Earning Date
  • SEPN 08-15-2025
  • BTBT 08-18-2025
  • Dividend Yield
  • SEPN N/A
  • BTBT N/A
  • EPS Growth
  • SEPN N/A
  • BTBT N/A
  • EPS
  • SEPN N/A
  • BTBT N/A
  • Revenue
  • SEPN $977,000.00
  • BTBT $102,037,923.00
  • Revenue This Year
  • SEPN N/A
  • BTBT $31.34
  • Revenue Next Year
  • SEPN $526.96
  • BTBT $40.97
  • P/E Ratio
  • SEPN N/A
  • BTBT N/A
  • Revenue Growth
  • SEPN 108.76
  • BTBT 52.44
  • 52 Week Low
  • SEPN $4.17
  • BTBT $1.69
  • 52 Week High
  • SEPN $28.99
  • BTBT $5.74
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • BTBT 45.66
  • Support Level
  • SEPN N/A
  • BTBT $2.47
  • Resistance Level
  • SEPN N/A
  • BTBT $2.66
  • Average True Range (ATR)
  • SEPN 0.00
  • BTBT 0.17
  • MACD
  • SEPN 0.00
  • BTBT -0.04
  • Stochastic Oscillator
  • SEPN 0.00
  • BTBT 2.38

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

Share on Social Networks: